Heave: Definition, Clinical Significance, and Overview

Heave Introduction (What it is)

Heave is a palpable lifting movement of the chest wall caused by the beating heart.
It is a clinical sign assessed during the cardiovascular physical examination.
It is commonly discussed in relation to ventricular hypertrophy, pressure overload, and cardiomegaly.
Heave is most often evaluated by precordial palpation at the left sternal border and near the apex beat.

Clinical role and significance

Heave matters because it can be an early, bedside clue to abnormal cardiac structure or loading conditions—especially right ventricular (RV) hypertrophy or left ventricular (LV) hypertrophy. In cardiology, it contributes to pattern recognition when integrated with symptoms, vital signs, and other exam findings (for example, jugular venous pressure (JVP), heart sounds, and murmurs).

Clinically, a Heave can:

• Support suspicion of pulmonary hypertension, chronic lung disease with RV strain (cor pulmonale), or congenital heart disease affecting RV afterload.
• Suggest LV pressure overload states such as aortic stenosis or longstanding systemic hypertension when the impulse is at or near the apex.
• Help triage which patients warrant targeted diagnostics such as electrocardiography (ECG), transthoracic echocardiography (TTE), and chest imaging.

Because it is a physical sign, its usefulness depends on examiner technique, patient habitus, and correlation with other data. It is not diagnostic on its own, but it can meaningfully increase or decrease pre-test probability for certain pathologies.

Indications / use cases

Heave is typically assessed in the following scenarios:

• Initial cardiovascular exam in patients with dyspnea, reduced exercise tolerance, chest symptoms, syncope, or edema
• Evaluation of suspected pulmonary hypertension or right-sided heart strain
• Assessment of possible valvular heart disease, especially lesions associated with pressure overload (for example, aortic stenosis)
• Examination of patients with suspected cardiomyopathy or cardiomegaly
• Follow-up exams where structural disease is known and trends in exam findings are tracked over time
• Bedside assessment in acute care settings alongside other signs (JVP, crackles, peripheral edema), recognizing that acuity and exam conditions can limit reliability

Contraindications / limitations

There are no true contraindications to assessing Heave because it is a noninvasive physical examination maneuver. The closest relevant issue is limited interpretability in certain contexts, where other approaches may be more informative:

• Obesity, thick chest wall musculature, or large breast tissue may reduce palpability
• Chronic obstructive pulmonary disease (COPD) or hyperinflation can displace the heart and dampen impulses
• Chest wall deformities (for example, pectus excavatum) can alter impulse location and transmission
• Tachycardia, significant patient discomfort, or inability to position the patient may make timing and characterization difficult
• Pericardial effusion can reduce the transmission of cardiac motion to the chest wall
• Mechanical ventilation or high positive end-expiratory pressure (PEEP) can change cardiothoracic mechanics and exam findings

When the physical exam is equivocal, clinicians often rely more heavily on TTE, ECG, and hemodynamic data. The relative value of each method varies by clinician and case.

How it works (Mechanism / physiology)

A Heave reflects increased force and/or altered direction of ventricular contraction transmitted to the chest wall. It is fundamentally a sign of ventricular workload and chamber remodeling, rather than a disease itself.

Key physiologic principles:

• Pressure overload (for example, pulmonary hypertension affecting the RV, or systemic hypertension affecting the LV) can lead to concentric hypertrophy. A thickened ventricle may generate a more sustained outward impulse.
• Volume overload can enlarge chambers and shift the point of maximal impulse (PMI), sometimes producing a more diffuse or displaced impulse. This may overlap with what examiners describe as a “heaving” or “hyperdynamic” precordium, depending on the pattern.
• Orientation and proximity matter: the RV lies anteriorly and can transmit motion to the left parasternal area, while the LV apex typically relates to the apex beat near the midclavicular line.

Relevant anatomy:

• Right ventricle: most anterior chamber; enlargement or hypertrophy often produces a parasternal Heave (classically at the left sternal border).
• Left ventricle: contributes to the apical impulse; LV hypertrophy or dilation can alter the character (sustained vs brisk) and location (displaced PMI).
• Interventricular septum and overall cardiac rotation can change where impulses are best felt.

Onset/duration/reversibility:

• Heave is not a therapy, so “onset and duration” do not apply in the usual pharmacologic sense.
• The exam finding can change over time if the underlying hemodynamics and remodeling change (for example, after treatment of hypertension or after progression of pulmonary vascular disease). The pace and degree of change vary by clinician and case.

Heave Procedure or application overview

Heave is assessed through structured cardiovascular palpation, typically as part of a complete exam.

General workflow (high level):

1. Evaluation/exam – Position the patient supine with the torso slightly elevated; clinicians may also use the left lateral decubitus position to better appreciate the apical impulse. – Inspect the precordium for visible impulses or abnormal motion.
2. Targeted palpation – Palpate the left sternal border using the heel of the hand to detect a parasternal lifting impulse (often associated with RV hypertrophy). – Palpate the apex/PMI with fingertips to assess location, size, and character (sustained vs brisk), noting any displacement. – Differentiate a Heave (a sustained lifting movement) from a thrill (a palpable vibration suggesting turbulent flow, often associated with significant murmurs).
3. Immediate checks and integration – Correlate with auscultation (S1/S2, added sounds such as S3/S4, and murmurs), peripheral pulses, blood pressure, and signs of congestion (JVP, edema, lung findings).
4. Diagnostics (when indicated) – ECG for evidence of ventricular hypertrophy, strain patterns, or conduction abnormalities. – TTE to assess chamber size, wall thickness, systolic function, valve lesions, and estimated pulmonary pressures. – Additional testing (for example, chest radiography, natriuretic peptides, or right heart catheterization) may be used depending on the clinical question; selection varies by clinician and case.
5. Follow-up/monitoring – Repeat exams may track whether the impulse changes alongside symptoms, imaging, and hemodynamics, recognizing inter-examiner variability.

Types / variations

Clinicians may describe Heave by location, timing, and quality, which helps narrow the differential diagnosis.

Common variations include:

• Parasternal Heave (left sternal border)
• Often associated with RV hypertrophy or RV dilation.
• Classically discussed in pulmonary hypertension, RV outflow obstruction, or certain congenital lesions.
• Apical Heave (at the apex/PMI)
• May be associated with LV hypertrophy (pressure overload) and described as sustained.
• LV dilation may produce a displaced and more diffuse apical impulse; terminology can vary among examiners.
• Sustained vs hyperdynamic impulse
• A sustained impulse is typically emphasized in pressure overload states.
• A hyperdynamic or “bounding” precordium may occur in high-output states or significant regurgitant lesions; how clinicians label this varies.
• Localized vs diffuse
• A localized impulse may point to a dominant chamber effect.
• A diffuse impulse can reflect enlargement, rotation, or increased overall cardiac motion.
• Associated palpable findings
• Thrills: vibratory sensations, often correlating with louder murmurs (for example, severe valvular stenosis).
• Tapping apex beat: sometimes described with mitral stenosis; whether it is labeled as Heave depends on teaching tradition and examiner interpretation.

Advantages and limitations

Advantages:

• Noninvasive, rapid, and can be performed at the bedside without equipment
• Helps build a hemodynamic and structural hypothesis early in assessment
• Can guide attention to key related findings (murmurs, JVP, peripheral edema, lung exam)
• Useful in resource-limited settings where imaging may not be immediately available
• Reinforces anatomical reasoning (RV anterior position; LV apex and PMI)
• Can be trended qualitatively across visits when performed consistently

Limitations:

• Sensitivity is reduced in patients with increased chest wall thickness, hyperinflation, or altered thoracic anatomy
• Considerable inter-observer variability in detecting and characterizing impulses
• Does not quantify chamber size, wall thickness, or pressure; it is not a standalone diagnostic test
• Findings can be confounded by tachycardia, patient positioning, anxiety, or movement
• Some disease states produce subtle or absent palpation findings despite significant pathology
• Labels (Heave vs hyperdynamic impulse vs displaced PMI) can differ among clinicians and training programs

Follow-up, monitoring, and outcomes

Heave itself is a sign, so “outcomes” relate to the underlying condition driving the impulse. Monitoring typically focuses on whether the suspected structural or hemodynamic abnormality is stable, improving, or progressing.

Factors that often influence monitoring strategy and clinical trajectory include:

• Severity and chronicity of underlying pressure or volume overload (for example, longstanding systemic hypertension vs advanced pulmonary hypertension)
• Comorbidities such as COPD, sleep-disordered breathing, thromboembolic disease, renal dysfunction, or anemia, which may shape cardiopulmonary load and symptoms
• Hemodynamics and ventricular function on echocardiography (RV size/function, LV ejection fraction, diastolic parameters), acknowledging that measurement methods vary by device, material, and institution
• Valve disease characteristics (stenosis vs regurgitation) and whether lesions are progressive
• Response to management (medical therapy, device therapy, interventions), recognizing that specific choices and expected changes vary by clinician and case
• Rehabilitation participation and functional status, often tracked with symptom class and exercise tolerance

In practice, a previously documented Heave may be rechecked during follow-up exams as part of a broader assessment that includes symptoms, vitals, auscultation findings, and imaging when indicated.

Alternatives / comparisons

Because Heave is a physical exam finding rather than a treatment, “alternatives” mainly refer to other ways of assessing the same underlying issues: chamber remodeling, ventricular function, and pressure/volume loading.

Common comparisons:

• Observation and serial physical exams
• Advantage: low cost and repeatable.
• Limitation: subjective and may miss early or subtle disease.
• ECG
• Can suggest LVH/RVH or strain patterns, but has limited sensitivity and specificity compared with imaging.
• Complements Heave by adding electrical and rhythm information.
• Transthoracic echocardiography (TTE)
• Often the primary tool to evaluate chamber size, hypertrophy, valve lesions, and estimated pulmonary pressures.
• More objective than Heave, but access and image quality vary by patient factors and institution.
• Chest radiography
• May show cardiomegaly or pulmonary vascular changes, but does not directly measure pressures or function.
• Cardiac magnetic resonance (CMR)
• Provides detailed ventricular volumes and tissue characterization; availability and indications vary.
• Right heart catheterization
• Gold-standard hemodynamics for pulmonary hypertension assessment in appropriate contexts, but invasive and not used solely because a Heave is present.

In most teaching pathways, Heave is used to refine the differential and prioritize confirmatory testing rather than replace it.

Heave Common questions (FAQ)

Q: Is a Heave the same as the apex beat or PMI?
No. The apex beat (PMI) refers to where the apical impulse is felt most strongly, while Heave describes the quality of a lifting, sustained impulse. A Heave can be parasternal (often RV-related) or apical (often LV-related), and clinicians integrate both location and character.

Q: What does a parasternal Heave suggest clinically?
A parasternal Heave classically raises suspicion for increased RV workload, such as RV hypertrophy. It is often discussed in the context of pulmonary hypertension or RV outflow obstruction. It is not diagnostic by itself and is interpreted alongside imaging and hemodynamics.

Q: Does a Heave mean the patient has heart failure?
Not necessarily. A Heave suggests altered ventricular mechanics (often hypertrophy or enlargement), which can be present with or without clinical heart failure. Heart failure assessment relies on symptoms, volume status, biomarkers (when used), and imaging findings.

Q: Is a Heave dangerous or an emergency finding?
A Heave is a physical sign, not an emergency diagnosis. Its significance depends on the clinical context—acute respiratory distress, hypotension, or syncope would prompt urgent evaluation regardless of whether a Heave is present. The degree of concern varies by clinician and case.

Q: Can a Heave be painful?
Heave itself is not typically described as painful; it is something the examiner feels rather than something the patient necessarily perceives. If a patient reports chest pain, clinicians evaluate it using standard chest pain assessment frameworks, as pain has a broad differential.

Q: Does assessing for Heave require anesthesia or special equipment?
No. It is assessed with inspection and palpation during the bedside cardiovascular exam. Equipment may be used afterward (for example, ECG or echocardiography) to evaluate suspected causes.

Q: If a Heave is found, what tests are commonly considered next?
Clinicians commonly correlate the finding with auscultation and other exam signs, then consider ECG and transthoracic echocardiography to assess chamber size, hypertrophy, valve disease, and estimated pressures. Additional testing depends on the suspected diagnosis and patient presentation.

Q: How long does a Heave “last” once it appears?
A Heave persists as long as the underlying hemodynamic or structural driver persists. If the underlying condition improves or progresses, the palpated impulse may change over time. The time course varies by clinician and case.

Q: Does finding a Heave change activity recommendations or restrictions?
A Heave alone does not determine activity guidance. Activity considerations are typically based on the underlying diagnosis (for example, severity of valve disease, pulmonary hypertension, or cardiomyopathy), symptoms, and objective testing. Specific recommendations are individualized by the treating team.

Q: What does it mean if a Heave is not present?
Absence of a Heave does not exclude significant heart disease. Some patients have minimal or difficult-to-detect precordial impulses due to body habitus or lung hyperinflation, and some conditions do not produce a prominent impulse. Clinicians rely on the complete clinical picture and diagnostic tests when indicated.